Yurokal Syrup contains Disodium Hydrogen Citrate 1.53 gm per 5 ml and is indicated primarily as an alkalinizing agent used to correct metabolic acidosis and to increase urinary pH in various clinical conditions. By acting as a systemic alkalizer, Yurokal Syrup facilitates the neutralization of excess acid in the blood and urine, thereby aiding in the management of conditions such as renal tubular acidosis, urinary tract infections, and certain types of kidney stones. The active ingredient, Disodium Hydrogen Citrate, functions by releasing citrate ions that bind hydrogen ions, resulting in an increased bicarbonate concentration and elevated urinary pH. This mechanism helps prevent the formation of uric acid and cystine stones and promotes the excretion of acidic metabolites. Yurokal Syrup is administered orally, with dosage tailored according to the patient’s clinical condition and response to therapy. It is generally well tolerated; however, caution is advised in patients with sodium-restricted diets, hypertension, or impaired renal function due to its sodium content. Adverse effects are uncommon but may include gastrointestinal disturbances such as nausea or abdominal discomfort. Yurokal Syrup should be used under medical supervision, ensuring appropriate monitoring of acid-base balance and electrolyte levels during treatment.